CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
102.89
4.99%
Market Trading Hours* (UTC) Open now
Closes on Monday at 20:00

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.16
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Cardinal Health Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 108.14
Open* 102.65
1-Year Change* 28.1%
Day's Range* 101.29 - 102.84
52 wk Range 68.53-108.85
Average Volume (10 days) 2.02M
Average Volume (3 months) 43.29M
Market Cap 26.22B
P/E Ratio 174.94
Shares Outstanding 246.47M
Revenue 210.17B
EPS 0.61
Dividend (Yield %) 1.88213
Beta 0.70
Next Earnings Date Feb 1, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 19, 2024 108.14 2.19 2.07% 105.95 108.34 105.58
Apr 18, 2024 105.91 -0.43 -0.40% 106.34 107.18 105.36
Apr 17, 2024 106.42 -0.61 -0.57% 107.03 107.47 106.16
Apr 16, 2024 107.09 1.03 0.97% 106.06 107.93 106.06
Apr 15, 2024 106.94 0.53 0.50% 106.41 108.21 106.24
Apr 12, 2024 104.99 -0.05 -0.05% 105.04 106.16 104.80
Apr 11, 2024 106.35 -1.29 -1.20% 107.64 108.01 105.95
Apr 10, 2024 107.86 1.35 1.27% 106.51 108.47 106.51
Apr 9, 2024 108.00 -0.90 -0.83% 108.90 109.44 106.29
Apr 8, 2024 109.38 0.07 0.06% 109.31 110.01 108.82
Apr 5, 2024 109.85 0.48 0.44% 109.37 110.83 109.37
Apr 4, 2024 110.03 -0.94 -0.85% 110.97 111.53 109.91
Apr 3, 2024 110.87 -0.22 -0.20% 111.09 112.27 110.23
Apr 2, 2024 111.14 0.02 0.02% 111.12 111.95 110.26
Apr 1, 2024 111.89 0.48 0.43% 111.41 112.16 110.14
Mar 28, 2024 111.80 -0.31 -0.28% 112.11 112.17 111.12
Mar 27, 2024 112.48 1.19 1.07% 111.29 112.50 110.54
Mar 26, 2024 111.55 0.88 0.80% 110.67 111.93 110.53
Mar 25, 2024 110.91 0.11 0.10% 110.80 111.75 110.35
Mar 22, 2024 110.91 -1.57 -1.40% 112.48 112.87 110.14

Cardinal Health Events

Time (UTC) Country Event
Thursday, May 2, 2024

Time (UTC)

12:30

Country

US

Event

Q3 2024 Cardinal Health Inc Earnings Call
Q3 2024 Cardinal Health Inc Earnings Call

Forecast

-

Previous

-

Time (UTC)

12:30

Country

US

Event

Q3 2024 Cardinal Health Inc Earnings Release
Q3 2024 Cardinal Health Inc Earnings Release

Forecast

-

Previous

-
Tuesday, August 13, 2024

Time (UTC)

12:30

Country

US

Event

Q4 2024 Cardinal Health Inc Earnings Release
Q4 2024 Cardinal Health Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 205012 181364 162467 152922 145534
Revenue 205012 181364 162467 152922 145534
Cost of Revenue, Total 198123 174819 155689 146054 138700
Gross Profit 6889 6545 6778 6868 6834
Total Operating Expense 204285 181970 162009 157036 143474
Selling/General/Admin. Expenses, Total 4834 4557 4533 4572 4480
Depreciation / Amortization 281 311 428 512 531
Unusual Expense (Income) 1047 2283 1359 5898 -237
Operating Income 727 -606 458 -4114 2060
Interest Income (Expense), Net Non-Operating -93 -147 -182 341 -307
Other, Net 4 -16 47 1 -2
Net Income Before Taxes 638 -769 323 -3772 1751
Net Income After Taxes 262 -932 612 -3693 1365
Minority Interest -1 -1 -1 -3 -2
Net Income Before Extra. Items 261 -933 611 -3696 1363
Total Extraordinary Items
Net Income 261 -933 611 -3696 1363
Income Available to Common Excl. Extra. Items 261 -933 611 -3696 1363
Income Available to Common Incl. Extra. Items 261 -933 611 -3696 1363
Dilution Adjustment
Diluted Net Income 261 -933 611 -3696 1363
Diluted Weighted Average Shares 262 279 294 293 301
Diluted EPS Excluding Extraordinary Items 0.99618 -3.34409 2.07823 -12.6143 4.52824
Dividends per Share - Common Stock Primary Issue 1.9828 1.9632 1.9436 1.9244 1.9052
Diluted Normalized EPS 2.64979 1.97706 5.02092 0.65853 3.91444
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 53453 50487 51469 49603 47103
Revenue 53453 50487 51469 49603 47103
Cost of Revenue, Total 51626 48702 49806 47989 45498
Gross Profit 1827 1785 1663 1614 1605
Total Operating Expense 53316 49915 51588 49466 47067
Selling/General/Admin. Expenses, Total 1267 1179 1191 1197 1155
Depreciation / Amortization 70 69 71 71 76
Unusual Expense (Income) 353 -35 520 209 338
Operating Income 137 572 -119 137 36
Interest Income (Expense), Net Non-Operating -15 -28 -25 -25 -34
Other, Net -1 0 7 -2 -30
Net Income Before Taxes 121 544 -137 110 -28
Net Income After Taxes -66 347 -130 111 137
Minority Interest 2 -2 0 -1 1
Net Income Before Extra. Items -64 345 -130 110 138
Net Income -64 345 -130 110 138
Income Available to Common Excl. Extra. Items -64 345 -130 110 138
Income Available to Common Incl. Extra. Items -64 345 -130 110 138
Diluted Net Income -64 345 -130 110 138
Diluted Weighted Average Shares 255 258 261 273 273
Diluted EPS Excluding Extraordinary Items -0.25098 1.33721 -0.49808 0.40293 0.50549
Dividends per Share - Common Stock Primary Issue 0.4957 0.4957 0.4957 0.4957 0.4908
Diluted Normalized EPS 0.64882 1.25068 0.80192 0.91484 1.31026
Total Adjustments to Net Income 0
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 33833 32935 31048 25940 25747
Cash and Short Term Investments 4043 4717 3407 2771 2531
Cash & Equivalents 4043 4717 3407 2771 2531
Total Receivables, Net 11344 10561 9103 8264 8448
Accounts Receivable - Trade, Net 11344 10561 9103 8264 8448
Total Inventory 15940 15636 14594 13198 12822
Prepaid Expenses 2362 2021 2843 1707 1940
Other Current Assets, Total 144 0 1101 6
Total Assets 43417 43878 44453 40766 40963
Property/Plant/Equipment, Total - Net 2897 2818 2820 2792 2356
Property/Plant/Equipment, Total - Gross 6754 6340 6048 5757 5168
Accumulated Depreciation, Total -3857 -3522 -3228 -2965 -2812
Goodwill, Net 4609 5855 7989 8357 8378
Intangibles, Net 1472 1774 2105 2918 3430
Other Long Term Assets, Total 606 496 491 759 1052
Total Current Liabilities 33706 30550 27624 23615 24109
Accounts Payable 29813 27128 23700 21374 21535
Accrued Expenses 3059 2842 2957 2231 2117
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 792 580 871 10 452
Other Current Liabilities, Total 42 0 96 5
Total Liabilities 46269 44587 42662 38977 34635
Total Long Term Debt 3909 4735 5365 6765 7579
Long Term Debt 3850 4686 5320 6740 7579
Deferred Income Tax 8278 8911 9296 8253 2945
Minority Interest 1 3 3 3 2
Other Liabilities, Total 375 388 374 341
Total Equity -2852 -709 1791 1789 6328
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 2747 2813 2806 2789 2763
Retained Earnings (Accumulated Deficit) -534 -280 1205 1170 5434
Treasury Stock - Common -4914 -3128 -2186 -2066 -1790
Other Equity, Total -151 -114 -34 -104 -79
Total Liabilities & Shareholders’ Equity 43417 43878 44453 40766 40963
Total Common Shares Outstanding 251 273 291 293 299
Capital Lease Obligations 59 49 45 25
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 34688 33833 33497 34596 32696
Cash and Short Term Investments 3854 4043 3990 3654 3492
Cash & Equivalents 3854 4043 3990 3654 3492
Total Receivables, Net 11265 11344 10992 11421 11039
Accounts Receivable - Trade, Net 11265 11344 10992 11421 11039
Total Inventory 16987 15940 16620 17263 15891
Prepaid Expenses 2582 2362 1895 2258 2274
Other Current Assets, Total 0 144
Total Assets 43710 43417 43377 44482 43387
Property/Plant/Equipment, Total - Net 2441 2462 2362 2341 2339
Goodwill, Net 4025 4609 5000 4986 5675
Intangibles, Net 1407 1472 1567 1632 1692
Other Long Term Assets, Total 1149 1041 951 927 985
Total Current Liabilities 35065 33706 32503 33212 31559
Accounts Payable 31540 29813 29601 30083 28362
Accrued Expenses 2737 3059 2876 2552 2619
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 788 792 26 577 578
Other Current Liabilities, Total 0 42
Total Liabilities 47201 46269 45597 46695 45168
Total Long Term Debt 3890 3909 4708 4685 4689
Long Term Debt 3890 3909 4708 4685 4689
Deferred Income Tax 8245 8653 8384 8797 8919
Minority Interest 1 1 2 1 1
Total Equity -3491 -2852 -2220 -2213 -1781
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 2728 2747 2818 2747 2576
Retained Earnings (Accumulated Deficit) -654 -534 -342 -560 -301
Treasury Stock - Common -5400 -4914 -4554 -4254 -3880
Other Equity, Total -165 -151 -142 -146 -176
Total Liabilities & Shareholders’ Equity 43710 43417 43377 44482 43387
Total Common Shares Outstanding 247 251 255 259 262
Capital Lease Obligations
Other Liabilities, Total
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -932 612 -3693 1365 259
Cash From Operating Activities 3231 2320 1960 2722 2764
Cash From Operating Activities 692 783 913 1000 1032
Deferred Taxes 7 496 -961 -83 -1012
Non-Cash Items 2231 140 -360 -315 1619
Cash Taxes Paid 766 273 368 311 425
Cash Interest Paid 153 182 226 285 320
Changes in Working Capital 1233 289 6061 755 866
Cash From Investing Activities 567 -378 493 338 -5608
Capital Expenditures -387 -400 -375 -328 -384
Other Investing Cash Flow Items, Total 954 22 868 666 -5224
Cash From Financing Activities -2463 -1317 -2200 -2293 -2276
Financing Cash Flow Items -19 26 120 -14 -144
Total Cash Dividends Paid -559 -573 -569 -577 -581
Issuance (Retirement) of Stock, Net -1000 -200 -350 -600 -550
Issuance (Retirement) of Debt, Net -885 -570 -1401 -1102 -1001
Foreign Exchange Effects -25 11 -13 1 4
Net Change in Cash 1310 636 240 768 -5116
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 328 -19 111 -932 -1069
Cash From Operating Activities 1981 620 23 3231 239
Cash From Operating Activities 516 341 171 692 513
Non-Cash Items 1031 970 205 2231 1886
Changes in Working Capital 106 -672 -464 1233 -1091
Cash From Investing Activities -248 -157 -70 567 771
Capital Expenditures -264 -155 -70 -387 -223
Other Investing Cash Flow Items, Total 16 -2 0 954 994
Cash From Financing Activities -2459 -1525 -1163 -2463 -2048
Financing Cash Flow Items 11 9 -14 -19 -26
Total Cash Dividends Paid -399 -271 -142 -559 -425
Issuance (Retirement) of Stock, Net -1500 -1250 -1000 -1000 -1000
Issuance (Retirement) of Debt, Net -571 -13 -7 -885 -597
Foreign Exchange Effects -1 -1 -15 -25 -13
Net Change in Cash -727 -1063 -1225 1310 -1051
Deferred Taxes 7

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Cardinal Health Company profile

About Cardinal Health Inc

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; provides pharmacy management services to hospitals; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources and distributes a range of medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. This segment also distributes a range of national brand products and provides supply chain services and solutions to hospitals and other healthcare providers.

Financial summary

BRIEF: For the six months ended 31 December 2021, Cardinal Health Inc revenues increased 11% to $89.43B. Net income decreased 15% to $320M. Revenues reflect Pharmaceutical segment increase of 12% to $81.2B, United States segment increase of 11% to $87.22B. Net income was offset by Medical segment income decrease of 63% to $173M, Corporate segment loss increase of 7% to $1.54B. Dividend per share increased from $0.97 to $1.47.

Equity composition

Common no Par, 3/11, 755M auth., 363,600,000 issd., less 13,300,000 in Treas. @ $487.2M. Insiders & Strategic holders own 0.10%. IPO:9/94, 7M shs @ $39 by Smith Barney. *FY'97 -'99 fncls & '98-'99 Q rest'd for merger with Scherer(8/98),llegiance (3/99), PSI(5/99), & ALP (9/99).

Industry: Pharmaceuticals Wholesale

7000 Cardinal Pl
DUBLIN
OHIO 43017
US

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

Gold

2,336.11 Price
-2.270% 1D Chg, %
Long position overnight fee -0.0195%
Short position overnight fee 0.0113%
Overnight fee time 21:00 (UTC)
Spread 0.40

XRP/USD

0.55 Price
+2.300% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,186.06 Price
+1.140% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

US100

17,087.90 Price
+0.270% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading